About Panakeia
Panakeia is a company based in London (United Kingdom) founded in 2018. Panakeia has raised $3.79 million across 2 funding rounds. The company has 12 employees as of December 31, 2021. Panakeia offers products and services including PANProfiler Colon and Multi-Omics Analysis. Panakeia operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Boston Medical Sciences and Evolved By Nature, among others.
- Headquarter London, United Kingdom
- Employees 12 as on 31 Dec, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Panakeia Technologies Limited
- Date of Incorporation 26 Nov, 2018
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.79 M (USD)
in 2 rounds
-
Latest Funding Round
$3.73 M (USD), Seed
Sep 26, 2019
-
Investors
Not available
-
Employee Count
12
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Panakeia
Panakeia offers a comprehensive portfolio of products and services, including PANProfiler Colon and Multi-Omics Analysis.
AI tool for molecular profiling in colon cancer diagnostics
Platform for comprehensive molecular analysis from tissue images
People of Panakeia
Unlock access to complete
Unlock access to complete
Funding Insights of Panakeia
Panakeia has successfully raised a total of $3.79M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.73 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Panakeia
Investment portfolio details for Panakeia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Panakeia
Detailed financials for Panakeia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Panakeia Comparisons
Peer comparison for Panakeia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Panakeia
Panakeia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Boston Medical Sciences and Evolved By Nature, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
Provider of machine language and computational platform for drug discovery
|
|
| Locked | Locked | Locked |
AI-powered colorectal cancer screening system
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
Detailed competitors of Panakeia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Panakeia
Complete news archive for Panakeia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panakeia
Panakeia was founded in 2018.
Panakeia is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Panakeia is a funded company, having raised a total of $3.79M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Panakeia is 12.
Panakeia was founded in 2018 in London, United Kingdom, as a provider of AI-based software focused on diagnosis and precision treatment for cancer prevention. Expertise is applied in biomarker discovery and validation, tissue phenomics, therapeutics, drug design, bioinformatics, and machine learning. Operations center on developing technologies for single-step diagnostics and targeted therapies within the healthcare sector.
Panakeia's top competitors include Asimov, Cellarity and Boston Medical Sciences.
Panakeia offers PANProfiler Colon and Multi-Omics Analysis.
The valuation of Panakeia is $10.73M as of Sep 2019.